Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27374 | 189 | 29.9 | 40% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 3130 | 1745 | ADRENERGIC DRUG//FLIP REGRESSION//ORBITAL NODES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FLIP REGRESSION | Author keyword | 9 | 83% | 3% | 5 |
| 2 | ORBITAL NODES | Author keyword | 6 | 80% | 2% | 4 |
| 3 | BENZODIAZEPINE RECEPTOR ACTIVITY | Author keyword | 3 | 100% | 2% | 3 |
| 4 | ZINDO 1 | Author keyword | 2 | 44% | 2% | 4 |
| 5 | CANNABINOID COMPOUNDS | Author keyword | 1 | 100% | 1% | 2 |
| 6 | PROGRAMA DOCTORADO FISICOQUIM MOL | Address | 1 | 50% | 1% | 2 |
| 7 | PSYCHOACTIVITY | Author keyword | 1 | 33% | 2% | 3 |
| 8 | ANTIMICROBIAL HYDRAZIDES | Author keyword | 1 | 50% | 1% | 1 |
| 9 | LATERAL VALIDATION | Author keyword | 1 | 50% | 1% | 1 |
| 10 | PROGRAMA DR FISICOQUIM MOL | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | FLIP REGRESSION | 9 | 83% | 3% | 5 | Search FLIP+REGRESSION | Search FLIP+REGRESSION |
| 2 | ORBITAL NODES | 6 | 80% | 2% | 4 | Search ORBITAL+NODES | Search ORBITAL+NODES |
| 3 | BENZODIAZEPINE RECEPTOR ACTIVITY | 3 | 100% | 2% | 3 | Search BENZODIAZEPINE+RECEPTOR+ACTIVITY | Search BENZODIAZEPINE+RECEPTOR+ACTIVITY |
| 4 | ZINDO 1 | 2 | 44% | 2% | 4 | Search ZINDO+1 | Search ZINDO+1 |
| 5 | CANNABINOID COMPOUNDS | 1 | 100% | 1% | 2 | Search CANNABINOID+COMPOUNDS | Search CANNABINOID+COMPOUNDS |
| 6 | PSYCHOACTIVITY | 1 | 33% | 2% | 3 | Search PSYCHOACTIVITY | Search PSYCHOACTIVITY |
| 7 | ANTIMICROBIAL HYDRAZIDES | 1 | 50% | 1% | 1 | Search ANTIMICROBIAL+HYDRAZIDES | Search ANTIMICROBIAL+HYDRAZIDES |
| 8 | LATERAL VALIDATION | 1 | 50% | 1% | 1 | Search LATERAL+VALIDATION | Search LATERAL+VALIDATION |
| 9 | PSYCHOINACTIVITY | 1 | 50% | 1% | 1 | Search PSYCHOINACTIVITY | Search PSYCHOINACTIVITY |
| 10 | QUANTUM CHEMICAL DESCRIBERS | 1 | 50% | 1% | 1 | Search QUANTUM+CHEMICAL+DESCRIBERS | Search QUANTUM+CHEMICAL+DESCRIBERS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ORBITAL PHASE ANGLES | 9 | 83% | 3% | 5 |
| 2 | PYRAZOLO4 5 CQUINOLINES | 8 | 100% | 3% | 5 |
| 3 | 1 2 4 TRIAZOLO1 5 AQUINOXALINES | 6 | 80% | 2% | 4 |
| 4 | QUANTUM THEORETIC QSAR | 4 | 56% | 3% | 5 |
| 5 | PHENYLALKYLAMINE HALLUCINOGENS | 3 | 57% | 2% | 4 |
| 6 | TRICYCLIC HETEROAROMATIC SYSTEMS | 2 | 24% | 4% | 8 |
| 7 | PSYCHOTOMIMETIC PHENYLALKYLAMINES | 2 | 50% | 2% | 3 |
| 8 | HYDROPHOBICITY PARAMETERS | 2 | 28% | 3% | 5 |
| 9 | ACTIVITY RELATIONSHIP SAR | 1 | 19% | 4% | 7 |
| 10 | FRONTIER ORBITAL ENERGIES | 1 | 33% | 2% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| QUANTUM CHEMICAL PROPERTIES USED IN STRUCTURE-ACTIVITY RELATIONSHIP STUDIES. | 2010 | 12 | 41 | 32% |
| QSAR STUDIES ON DRUGS ACTING AT THE CENTRAL NERVOUS-SYSTEM | 1989 | 60 | 52 | 21% |
| QSAR STUDIES ON HALLUCINOGENS | 1983 | 43 | 12 | 58% |
| Transport parameter dependence on intermolecular forces | 1995 | 0 | 5 | 60% |
| An Overview on Synthetic Methodologies and Biological Activities of Pyrazoloquinolines | 2010 | 6 | 61 | 10% |
| QSAR STUDIES ON ENZYME-INHIBITORS | 1987 | 54 | 72 | 13% |
| Quantitative structure-activity relationships of antiarrhythmic drugs | 1998 | 2 | 39 | 13% |
| A review of molecular modeling approaches to pharmacophore models and structure-activity relationships of ion channel modulators in CNS | 2002 | 13 | 150 | 3% |
| STRUCTURE-ACTIVITY-RELATIONSHIPS OF PHENETHYLAMINE HALLUCINOGENS | 1981 | 34 | 5 | 20% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROGRAMA DOCTORADO FISICOQUIM MOL | 1 | 50% | 1.1% | 2 |
| 2 | PROGRAMA DR FISICOQUIM MOL | 1 | 50% | 0.5% | 1 |
| 3 | METODOL ENSINO EDUC COMPARADA | 0 | 20% | 1.1% | 2 |
| 4 | CIENCIA COMPUTACAO ESTATIST | 0 | 25% | 0.5% | 1 |
| 5 | CIENCIAS MEDICAS | 0 | 14% | 0.5% | 1 |
| 6 | CIENCIAS COMPUTACAO ESTAT | 0 | 11% | 0.5% | 1 |
| 7 | CIENCIA COMPUTAC ESTATIST | 0 | 100% | 0.5% | 1 |
| 8 | ECOL RECURSOS NAT REPUBL 275 | 0 | 100% | 0.5% | 1 |
| 9 | ESCOLA ARIES CIENCIAS HUMANIDADES | 0 | 100% | 0.5% | 1 |
| 10 | QUIM UFPB | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000252913 | ALPHA BLOCKING ACTIVITY//NON LINEAR PRINCIPAL COMPONENT ANALYSIS NPCA//AGR CHEM SAKYO KU |
| 2 | 0.0000131540 | MALCOLM H FILSON S//INTEGRAL APPROXIMATIONS ACCORDING TO MULLIKEN AND RUDENBERG//NEGLECT OF DIATOMIC DIFFERENTIAL OVERLAP NDDO |
| 3 | 0.0000123106 | CP MLR//HAM 3//COMBINATORIAL PROTOCOL IN MULTIPLE LINEAR REGRESSION |
| 4 | 0.0000120736 | ENGN CHEM KANAGAWA KU//PHOSPHOLIPID OLEIC ACID MONOLAYERS//POLYETHYLENE OXIDE LIPID |
| 5 | 0.0000112546 | 2 3 4 5 TETRAHYDRO 1H 2 AZEPINE//2 3 4 5 TETRAHYDRO 1H 3 BENZAZEPINE//A RING CATECHOL |
| 6 | 0.0000096976 | BARRIERS IN PROTEINS//COMPUTER NEURAL NETWORKS//HIGHER EDUCATION PROGRAMMES |
| 7 | 0.0000095480 | 5 HT2C RECEPTOR//5 HT2C RECEPTORS//5 HT2A RECEPTOR |
| 8 | 0.0000085509 | 1 BENZOXEPIN 5 ONES//BIOPHYS TSUKIJI 5 CHOME CHUO KU//MOTIONAL CORRELATION TIMES |
| 9 | 0.0000079868 | FENTICONAZOLE//FARM IST MICROBIOL//FENTICONAZOLE NITRATE |
| 10 | 0.0000075120 | BRETAZENIL//ABECARNIL//FLUMAZENIL |